Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants

Author(s):

Alexander J. Thompson, Kathy Jackson, Sara Bonanzinga, Sam A.L. Hall, Simon Hume, Gareth S. Burns, Vijaya Sundararajan, Dilip Ratnam, Miriam T. Levy, John Lubel, Amanda J. Nicoll, Simone I. Strasser, William Sievert, Paul V. Desmond, Meng C. Ngu, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A. Revill, Margaret Littlejohn, D. Scott Bowden, Jesse A. Canchola, Jason Torres, Philip Siew, Jasmin Lau, Benjamin La Brot, Alison Kuchta, Kumar Visvanathan

Details:

Hepatology Communications, Volume 7, Issue 8, 2023-08-01, Article number e0188

Article Link: Click here

Affiliations:

• Concord Repatriation General Hospital
• University of Melbourne
• The University of Sydney
• St. Vincent's Hospital Sydney
• Bankstown-Lidcombe Hospital
• Roche Molecular Systems
• Monash University
• Royal Prince Alfred Hospital
• Monash Health
• Faculty of Medicine, Nursing and Health Sciences
• Eastern Health
• La Trobe University
• Royal Melbourne Hospital
• Austin Health
• St. Vincent's Hospital Melbourne
• Liverpool Hospital
• Novartis Pty Ltd.
• Alfred Health